Hostname: page-component-55f67697df-q9hcs Total loading time: 0 Render date: 2025-05-09T00:34:10.330Z Has data issue: false hasContentIssue false

High specificity electrocardiogram patterns for parvovirus B19 myocarditis in children: bridging electrocardiogram findings to aetiological diagnosis

Published online by Cambridge University Press:  08 May 2025

Roger Esmel-Vilomara*
Affiliation:
Faculty of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain Paediatric Cardiology, Vall d’Hebron Hospital Campus, Barcelona, Spain Paediatric Cardiology, Hospital de la Santa Creu i Sant Pau, Institut de Recerca Sant Pau (IR-Sant Pau), Barcelona, Spain
Paola Dolader
Affiliation:
Faculty of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain Paediatric Cardiology, Vall d’Hebron Hospital Campus, Barcelona, Spain
Susana Melendo
Affiliation:
Faculty of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain Paediatric Infectious Diseases and Immunodeficiencies, Vall d’Hebron Hospital Campus, Barcelona, Spain
Ferran Rosés-Noguer
Affiliation:
Faculty of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain Paediatric Cardiology, Vall d’Hebron Hospital Campus, Barcelona, Spain
Ferran Gran
Affiliation:
Faculty of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain Paediatric Cardiology, Vall d’Hebron Hospital Campus, Barcelona, Spain
*
Corresponding author: Roger Esmel-Vilomara; Email: [email protected]
Rights & Permissions [Opens in a new window]

Abstract

Introduction:

Parvovirus B19 (PVB19) myocarditis is a life-threatening condition with high morbidity and mortality in children. While electrocardiograms are commonly used in the early assessment of myocarditis, no specific electrocardiogram pattern has been consistently linked to PVB19. The objective of this study is to identify a distinctive electrocardiogram pattern associated with PVB19 myocarditis and evaluate its diagnostic accuracy.

Methods:

This retrospective case–control study included 77 paediatric patients diagnosed with acute myocarditis at a single centre in Barcelona over 16 years (August 2008–September 2024). Twenty patients had PVB19 myocarditis, confirmed by polymerase chain reaction in blood or endomyocardial biopsy, while 57 patients had myocarditis caused by other viruses. Electrocardiogram were assessed by three cardiologists blinded to the aetiological diagnosis.

Results:

A specific electrocardiogram pattern in the limb leads, characterised by peaked P waves, low QRS complex voltages, and altered repolarisation (manifesting as negative or flat T waves, with or without QTc prolongation), was observed in 14 of 20 patients (70%) with PVB19 myocarditis. Two additional patients exhibited low voltages and altered repolarisation without peaked P waves, and all demonstrated repolarisation abnormalities. In contrast, only 1 of 57 patients with myocarditis from other viruses exhibited the full electrocardiogram pattern. The pattern demonstrated a specificity of 98% and a sensitivity of 70% for PVB19 myocarditis.

Conclusion:

The identified electrocardiogram pattern shows strong diagnostic specificity for PVB19 myocarditis in paediatric patients and may serve as a useful early diagnostic tool. Further multicentre studies are needed to confirm these findings and explore their clinical implications.

Type
Original Article
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution and reproduction, provided the original article is properly cited.
Copyright
© The Author(s), 2025. Published by Cambridge University Press

Introduction

Myocarditis is an inflammatory disease of the heart primarily caused by viral infections . Reference Caforio, Pankuweit and Arbustini1,Reference Pomiato, Perrone, Palmieri and Gagliardi2 Its incidence is estimated at 10 to 20 cases per 100,000 individuals, and it represents a significant cause of morbidity and mortality in children. Reference Pomiato, Perrone, Palmieri and Gagliardi2Reference Krych, Jęczmyk and Jurkiewicz4 Among the responsible viral agents, Parvovirus B19 (PVB19) has emerged as the leading cause in the paediatric population. Reference Krych, Jęczmyk and Jurkiewicz4Reference Verdonschot, Hazebroek and Merken6 Nonetheless, a limited number of published series focuses specifically on PVB19 myocarditis in children. Reference Esmel-Vilomara, Dolader and Izquierdo-Blasco5,Reference Molina, Garcia and Denfield7,Reference Vigneswaran, Brown, Breuer and Burch8

The clinical presentation of myocarditis varies widely, from asymptomatic forms to life-threatening conditions such as cardiogenic shock or sudden cardiac death. Reference Caforio, Pankuweit and Arbustini1Reference Ammirati, Frigerio and Adler3 This nonspecific clinical presentation increases the risk of misdiagnosis or delays in diagnosis, which can delay the initiation of treatment and negatively impact survival chances. Reference Krych, Jęczmyk and Jurkiewicz4,Reference Buttà, Zappia, Laterra and Roberto9

The electrocardiogram is a readily available, low-cost diagnostic tool frequently utilised initial assessment of suspected myocarditis. Reference Caforio, Pankuweit and Arbustini1,Reference Ammirati, Frigerio and Adler3,Reference Buttà, Zappia, Laterra and Roberto9,Reference Pompa, Beerman, Feingold and Arora10 Although electrocardiogram abnormalities are found in nearly all children with myocarditis, no distinctive electrocardiographic changes can definitively diagnose the condition, and the test has limited sensitivity and specificity. Reference Buttà, Zappia, Laterra and Roberto9Reference Punja, Mark, McCoy, Javan, Pines and Brady11

This study aims to evaluate the electrocardiogram changes in paediatric patients with PVB19 myocarditis and determine whether a specific electrocardiogram pattern is associated with PVB19.

Methods

We performed a retrospective case control study including 77 consecutive paediatric patients diagnosed with acute myocarditis in a single centre in Barcelona over 16 years (August 2008 to September 2024). Inclusion criteria required a diagnostic confirmation by endomyocardial biopsy or cardiac MRI, with the myocarditis viral aetiology confirmed by polymerase chain reaction testing on endomyocardial biopsy or blood samples. Twenty patients were attributed to PVB19 (Group A), whereas the other 57 were caused by other viruses (Group B).

Demographics, initial presentation, severity of illness, aetiology, echocardiographic assessment, and electrocardiogram analysis were studied for both groups. Standard 12-lead electrocardiograms upon admission were evaluated by three cardiologists who were blinded to the aetiological diagnosis and Group A and B electrocardiogram were compared.

Statistical analysis was conducted using SPSS for Windows version 25.0 (Armonk, NY, USA: IBM Corp.). Categorical data were described using proportions, while quantitative continuous data were expressed as medians with interquartile ranges, given the non-normal distribution of the sample. Comparisons were made using Fisher’s exact test for categorical data and the Mann–Whitney U test for continuous variables.

Ethical approval for this study was granted by the local ethics committee, ensuring compliance with ethical standards and the protection of participants’ rights and safety. All activities conducted in this research adhered to the ethical principles outlined in the 1975 Declaration of Helsinki. Informed consent for publication was obtained from the parents of each patient.

Results

A total of 20 episodes of myocarditis involving 19 patients were identified. The median age was 19 months, and 13 (65%) were male. All patients presented with complicated myocarditis, manifesting either as heart failure, fulminant myocarditis or ventricular tachycardia, and requiring mechanical circulatory support with extracorporeal membrane oxygenation in 7 patients (35%). Detailed epidemiological and clinical data are shown in Table 1.

Table 1. Demographic inf ormation, clinical presentation, and electrocardiographic abnormalities upon presentation. Categorical data is presented as n (%) and continuous variables as median and interquartile ranges (IQR)

PVB19 PCR, parvovirus B19 polymerase chain reaction.

All patients exhibited abnormal electrocardiogram findings at presentation. Electrocardiogram abnormalities are detailed in Table 1. A specific pattern in the limb leads, characterised by peaked P waves, low QRS voltages and altered repolarisation (manifesting as negative or flat T waves with or without QTc prolongation), was observed in 14 patients (14/20, 70%). Notably, all patients had altered repolarisation (100%). In addition to the 14 patients with the complete pattern, two additional patients showed low voltages and altered repolarisation without peaked P waves.

Figure 1 provides examples of the described electrocardiogram pattern. The presence of more severe myocardial dysfunction (p = 0.323) or pericardial effusion (p = 0.521) was not associated with the described electrocardiogram pattern or any specific electrocardiogram finding independently.

Figure 1. Examples of the PVB19 ECG pattern presented in the limb leads: peaked p waves, low QRS voltages, and repolarisation abnormalities (manifested as negative or flat T waves).

During the same period, 57 patients with myocarditis not attributable to PVB19 were included, of whom 35 (35/57, 61.4%) presented with complicated myocarditis, including cardiogenic shock or heart failure. Among these patients, only one exhibited the complete electrocardiogram pattern described in the limb leads (1/57, 1.8%). Twenty patients presented an abnormal repolarisation (20/57, 35.1%), ten exhibited low voltages (10/57, 17.5%), and five had peaked P waves (8.8%).

These findings suggest that the described electrocardiogram pattern is significantly associated with PVB19 myocarditis (p < 0.001), showing a specificity of 98% and a sensitivity of 70% for identifying PVB19 in patients with myocarditis.

Discussion

Electrocardiogram is universally recommended as a first-line investigation for patients with suspected myocarditis. Reference Caforio, Pankuweit and Arbustini1,Reference Pomiato, Perrone, Palmieri and Gagliardi2 Numerous retrospective studies have demonstrated that electrocardiogram abnormalities are detected in nearly all patients, Reference Buttà, Zappia, Laterra and Roberto9,Reference Punja, Mark, McCoy, Javan, Pines and Brady11 although some studies report a subset of patients with normal electrocardiogram findings. Reference Pompa, Beerman, Feingold and Arora10 However, the potential association between specific electrocardiogram patterns and a particular causative agent has not yet been studied, particularly in paediatric populations where research is limited, and sample sizes are smaller. This study is the first to present an electrocardiogram pattern that could potentially help identify PVB19 as the underlying cause of myocarditis in paediatric patients.

Previous studies examining electrocardiogram alterations during acute myocarditis have identified sinus tachycardia and repolarisation abnormalities, particularly T-wave inversion, as the most common electrocardiogram findings. Reference Buttà, Zappia, Laterra and Roberto9,Reference Punja, Mark, McCoy, Javan, Pines and Brady11 In our study, repolarisation abnormalities were observed in all patients with PVB19 myocarditis, compared to 35.1% of patients with myocarditis caused by other virus. Repolarisation abnormalities have been reported in patients with myocarditis of varying severity, from non-complicated to fulminant myocarditis, with a prevalence ranging from 9 to 48%. Reference Buttà, Zappia, Laterra and Roberto9,Reference Punja, Mark, McCoy, Javan, Pines and Brady11,Reference De Lazzari, Zorzi and Baritussio12

The pathogenic link between myocardial oedema and repolarisation abnormalities remains to be fully elucidated. However, it has been proposed that regional or transmural myocyte repolarisation inhomogeneity secondary to the inflammatory process could be responsible. Reference Buttà, Zappia, Laterra and Roberto9,Reference De Lazzari, Zorzi and Baritussio12 In this context, T-wave inversion may result from inflammatory or fibrotic infiltration beginning in the subepicardium, where depolarisation and repolarisation become more delayed compared to the subendocardium, leading to a transmural repolarisation gradient. Reference Aimo, Milandri and Barison13 In line with this hypothesis, T-wave inversion has been independently associated with the extent of myocardial necrosis and oedema detected by MRI, with transmural oedema distribution strongly correlated with the location of T-wave inversion.Reference De Lazzari, Zorzi and Baritussio12

Low QRS voltages were observed in 16 of our patients (16/20, 80%), a finding traditionally associated with pericardial effusion or extracardiac conditions such as obesity or emphysema. Reference Aimo, Milandri and Barison13 However, low QRS voltages have also been documented in myocarditis independent of pericardial effusion, Reference Punja, Mark, McCoy, Javan, Pines and Brady11 a finding confirmed by this study. The proposed mechanisms for low QRS voltages in this setting include expansion of extracellular spaces by oedema and fibrosis in the ventricular wall. Pulmonary or peripheral oedema can also contribute to reducing voltage amplitude by increasing impedance to electrical conduction. Reference Buttà, Zappia, Laterra and Roberto9 In cardiomyopathies, low QRS voltages are observed in 3–6% of patients with dilated cardiomyopathy and in up to 41% of patients with certain forms of non-dilated left ventricular cardiomyopathy. Reference Aimo, Milandri and Barison13 The markedly higher prevalence of low voltages in PVB19 myocarditis in our cohort (80%) highlights the relevance of this electrocardiogram finding in this specific aetiology.

Additionally, peaked p waves on electrocardiograms, which indicate increased atrial pressures, are often a consequence of heart failure. Concurrently, myocardial oedema can further diminish ventricular compliance, exacerbating atrial pressure by creating a restrictive filling pattern and diastolic dysfunction. The impaired ventricular contraction and relaxation can also lead to atrioventricular valve regurgitation, further exacerbating atrial volume overload and pressure elevation. Reference Aimo, Milandri and Barison13

Although electrocardiogram is widely used for the early screening of myocarditis, Reference Caforio, Pankuweit and Arbustini1,Reference Ammirati, Frigerio and Adler3,Reference Pompa, Beerman, Feingold and Arora10 its sensitivity and specificity for diagnosing myocarditis remain low. Reference Pomiato, Perrone, Palmieri and Gagliardi2,Reference Buttà, Zappia, Laterra and Roberto9,Reference Pompa, Beerman, Feingold and Arora10 However, once myocarditis is suspected, the presence of this specific electrocardiogram pattern in the limb leads (characterised by peaked p waves, low QRS voltages and abnormal repolarisation) should prompt consideration of PVB19 as the likely cause, with a specificity of 98%. The sensitivity of this pattern, while lower at 70%, is still noteworthy. These findings could have significant clinical implications, not only guiding the selection of appropriate diagnostic tests but also influencing therapeutic decisions.

In particular, recent studies have proposed that immunosuppressive treatment, potentially combined with interferon-beta to suppress active PVB19 transcription in the myocardium, might offer an effective strategy for managing PVB19 myocarditis. Reference Krych, Jęczmyk and Jurkiewicz4,Reference Esmel-Vilomara, Dolader and Izquierdo-Blasco5,Reference He, Li and Li14 However, in the absence of definitive evidence, targeted immunosuppressive or antiviral therapy should not be initiated based solely on electrocardiogram findings without microbiological confirmation. While early empirical immunomodulatory treatment with corticosteroids may be considered in critically ill patients with cardiogenic shock or severe systolic dysfunction, particularly if this characteristic electrocardiogram pattern is present, this approach remains untested in clinical trials. Reference Pomiato, Perrone, Palmieri and Gagliardi2,Reference He, Li and Li14 Current guidelines do not provide specific recommendations for empiric immunosuppression in acute myocarditis beyond standard heart failure management. Reference Caforio, Pankuweit and Arbustini1,Reference Ammirati, Frigerio and Adler3

Beyond specialised centres where endomyocardial biopsy is routinely available, this electrocardiogram pattern could serve as a practical and widely accessible tool to aid in the early identification and risk stratification of paediatric myocarditis, particularly in resource-limited settings where advanced diagnostic tools as endomyocardial biopsy or cardiac MRI are not readily available. If validated in larger multicentre studies, its application could contribute to earlier clinical suspicion, optimised diagnostic workflows, and potentially improved patient outcomes.

The primary limitation of this study is its single-centre design, which may impact the generalisability of the findings. Additionally, the small sample size of 20 patients with PVB19 myocarditis, due to the rarity of the disease, restricts the robustness of the conclusions. To validate these results and enhance clinical applicability, future prospective multicentre studies with larger, well-characterised cohorts are needed. These studies should aim to confirm the specificity and sensitivity of this electrocardiogram pattern and assess its predictive value in clinical decision-making. Furthermore, expanding the number of centres and patients would facilitate an evaluation of interobserver agreement, ensuring consistent electrocardiogram interpretation in routine practice.

Conclusion

This study identifies a specific electrocardiogram pattern associated with PVB19 myocarditis in paediatric patients, characterised by peaked P waves, low QRS voltages, and abnormal repolarisation. This pattern demonstrates a high specificity (98%) for PVB19 myocarditis and a sensitivity of 70%. These findings can help in distinguishing PVB19 myocarditis from other aetiologies from the first medical evaluation, guiding clinicians towards appropriate diagnostic and therapeutic strategies. To validate these findings, further research involving larger, multicentric cohorts is essential to confirm the pattern’s clinical utility and explore its underlying mechanisms.

Acknowledgements

None.

Financial support

This research received no specific grant from any funding agency, commercial, or not-for-profit sectors.

Competing interests

The authors have no conflicts of interest relevant to this article to disclose.

Ethical standards

The authors assert that all procedures contributing to this work comply with the ethical standards of the relevant national Spanish guidelines on human experimentation and with the Helsinki Declaration of 1975, as revised in 2008, and has been approved by the Vall d’Hebron Hospital Ethics Committee.

References

Caforio, AL, Pankuweit, S, Arbustini, E, et al. Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European society of cardiology working group on myocardial and pericardial diseases. Eur Heart J 2013; 34: 26362648d. doi: 10.1093/eurheartj/eht210.CrossRefGoogle Scholar
Pomiato, E, Perrone, MA, Palmieri, R, Gagliardi, MG. Pediatric myocarditis: what have we learnt so far? J Cardiovasc Dev Dis 2022; 9: 143. doi: 10.3390/jcdd9050143. Published 2022 May 3.Google ScholarPubMed
Ammirati, E, Frigerio, M, Adler, ED, et al. Management of acute myocarditis and chronic inflammatory cardiomyopathy: an expert consensus document. Circ Heart Fail 2020; 13: e007405. doi: 10.1161/CIRCHEARTFAILURE.120.007405.CrossRefGoogle ScholarPubMed
Krych, S, Jęczmyk, A, Jurkiewicz, M, et al. Viral myocarditis as a factor leading to the development of heart failure symptoms, including the role of parvovirus B19 infection-systematic review. Int J Mol Sci 2024; 25: 8127. doi: 10.3390/ijms25158127. Published 2024 Jul 25.CrossRefGoogle Scholar
Esmel-Vilomara, R, Dolader, P, Izquierdo-Blasco, J, et al. Parvovirus B19 myocarditis in children: a diagnostic and therapeutic approach. Eur J Pediatr 2022; 181: 20452053. doi: 10.1007/s00431-022-04406-x.CrossRefGoogle ScholarPubMed
Verdonschot, J, Hazebroek, M, Merken, J, et al. Relevance of cardiac parvovirus B19 in myocarditis and dilated cardiomyopathy: review of the literature. Eur J Heart Fail 2016; 18: 14301441. doi: 10.1002/ejhf.665.CrossRefGoogle ScholarPubMed
Molina, KM, Garcia, X, Denfield, SW, et al. Parvovirus B19 myocarditis causes significant morbidity and mortality in children. Pediatr Cardiol 2013; 34: 390397. doi: 10.1007/s00246-012-0468-4.CrossRefGoogle ScholarPubMed
Vigneswaran, TV, Brown, JR, Breuer, J, Burch, M. Parvovirus B19 myocarditis in children: an observational study. Arch Dis Child 2016; 101: 177180. doi: 10.1136/archdischild-2014-308080.CrossRefGoogle ScholarPubMed
Buttà, C, Zappia, L, Laterra, G, Roberto, M. Diagnostic and prognostic role of electrocardiogram in acute myocarditis: a comprehensive review. Ann Noninvasive Electrocardiol 2020; 25: e12726. doi: 10.1111/anec.12726.CrossRefGoogle ScholarPubMed
Pompa, AG, Beerman, LB, Feingold, B, Arora, G. Electrocardiogram changes in pediatric patients with myocarditis. Am J Emerg Med 2022; 59: 4953. doi: 10.1016/j.ajem.2022.06.027.CrossRefGoogle ScholarPubMed
Punja, M, Mark, DG, McCoy, JV, Javan, R, Pines, JM, Brady, W. Electrocardiographic manifestations of cardiac infectious-inflammatory disorders. Am J Emerg Med 2010; 28: 364377. doi: 10.1016/j.ajem.2008.12.017.CrossRefGoogle ScholarPubMed
De Lazzari, M, Zorzi, A, Baritussio, A, et al. Relationship between T-wave inversion and transmural myocardial edema as evidenced by cardiac magnetic resonance in patients with clinically suspected acute myocarditis: clinical and prognostic implications. J Electrocardiol 2016; 49: 587595. doi: 10.1016/j.jelectrocard.2016.04.002.CrossRefGoogle ScholarPubMed
Aimo, A, Milandri, A, Barison, A, et al. Electrocardiographic abnormalities in patients with cardiomyopathies. Heart Fail Rev 2024; 29: 151164. doi: 10.1007/s10741-023-10358-7.CrossRefGoogle ScholarPubMed
He, B, Li, X, Li, D. Immunosuppressive treatment for myocarditis in the pediatric population: a meta-analysis. Front Pediatr 2019; 7: 430. doi: 10.3389/fped.2019.00430.CrossRefGoogle ScholarPubMed
Figure 0

Table 1. Demographic inf ormation, clinical presentation, and electrocardiographic abnormalities upon presentation. Categorical data is presented as n (%) and continuous variables as median and interquartile ranges (IQR)

Figure 1

Figure 1. Examples of the PVB19 ECG pattern presented in the limb leads: peaked p waves, low QRS voltages, and repolarisation abnormalities (manifested as negative or flat T waves).